Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
Its current CEO is Miles White. Abbott is now comprised of four equally-sized businesses – diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. According to its ...
Despite challenges, ongoing innovation and awareness are fueling market growth, with both branded and generic antibiotics ...
MTG Aetherdrift cards focus on a few major things: vehicles, speed, and vehicles again. However, somehow, the best cards are ...
"And a foray into branded generics is a step towards widening the avenues of growth." Besides significant presence of MNCs like Pfizer and Abbott (through Piramal) in cough and cold preparations ...
Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive innovation ...
Homeowners have been slugged a whopping $54,000 in extra repayments on their mortgages in Sydney as a result of interest rate rises since the election of the Albanese Government but can only expect ...
This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?
4d
Comic Book Resources on MSNRyan Gosling Exiting the Remake of an 84-Year-Old Classic Is Horror's Biggest Wasted OpportunityInitial designs for Wolf Man 2025 were a lot more exciting than what was made, especially given the ties to a popular horror ...
The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results